In agreement with previous work regarding inflammatory biomarkers associated with T2DM, our results show significantly higher IL-6, CRP (43), and IL1-β (38), and significantly lower IL-10 levels and IGF-1 (55) in T2DM in comparison to controls. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.